Target gene specific editing form enrichment method based on RNA sensing system

By introducing RNA sensing system into host cells, using ADAR adenosine deaminase to identify specific edited forms of RNA, the randomness and uncontrollability of mutation detection in genome editing technology is solved, and the efficiency of specific editing forms of target genes is achieved Enrichment and precise detection simplify the research process of gene function.

CN118910162APending Publication Date: 2024-11-08GERMPLASM INNOVATION GRAND SCIENCE CENTER OF WESTERN CHINA (CHONGQING) SCIENCE CITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410975549.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing genome editing techniques are random and uncontrollable when accurately detecting mutations caused by genome editing, which makes it difficult to identify a single mutation form of target genes, and traditional methods are time-consuming and costly.

Method used

Using the target gene-specific editing form enrichment method based on the RNA sensing system, the target gene-specific editing form is recognized by using ADAR adenosine deaminase to visualize and sort the target gene-specific editing form by visualizing and sorting Enrichment avoids the introduction of exogenous markers to the genome.

Benefits of technology

Accurate detection of target DNA mutations in living cells is achieved, the enrichment process of specific editing forms of target genes is simplified, the cost and time of experiments is reduced, and the efficiency of gene function research is improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910162A_ABST
    Figure CN118910162A_ABST
Patent Text Reader

Abstract

The invention discloses a target gene specific editing form enrichment system based on RNA induction, which utilizes adenosine deaminase (ADAR) mediated RNA editing to combine the detection of target gene mRNA and the translation of reporter gene, and utilizes CRISPR / Cas9; the method comprises the following steps of: performing prime edging; and the base editing system is used for editing the target gene. Cells containing a specific editing form of a target gene are enriched through expression level change of a report gene. The method disclosed by the invention can play a role in different organisms in a simple, universal and generalizable manner, can effectively enrich the specific editing form of the target gene, lays a solid foundation for large-scale application of a genome editing technology, development of a novel gene editing tool and gene function research, and has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and in particular relates to a method for enriching a target gene in a specific editing form based on an RNA sensing system. Background Art

[0002] The birth of genome editing technology is a milestone in the field of life science research. Reverse genetics research methods based on genome editing, as well as genome resequencing and whole genome editing technologies, have brought gene function research into the post-genomic era. On this basis, new genome editing tools, such as single-base editing and lead editing, have emerged in an endless stream, enabling people to engineer and edit target genes in a more precise manner. Genome editing technology has the advantages of programmability, simplicity, no need for exogenous DNA integration, and traceless repair. It also has great application prospects in agricultural breeding, environmental control, and genetic disease treatment.

[0003] However, despite the great achievements and widespread applications of genome editing, accurate detection of mutations caused by genome editing remains a challenge because most genome editing does not involve the combination of any selection markers. Unlike traditional site-specific recombinase (cre-lox; att-phiC31, etc.) systems, the commonly used genome editing technologies (TALEN; CRISPR, etc.) now rely on NHEJ repair with a high mismatch rate after DSB is generated in the genome, which inactivates the gene through frameshift mutation. The advantages of these technologies are simple design and use, but the disadvantages are the randomness, diversity and uncontrollability of NHEJ repair. Different mutation forms also have different degrees of influence on gene function, and the mixed editing forms produced after NHEJ repair will affect the singleness of variables in the research process, which undoubtedly has an adverse effect on gene function research. Therefore, identifying and selecting single mutation forms of pure target genes is an important link in the gene function process.

[0004] At present, the editing form of the target site of the target gene is mostly identified by sequencing after separate sampling, which often requires culturing a large number of mutant cells or passing the chimeric individuals into a large number of mutant individuals by test cross, and then sorting single cells by flow cytometry or separating mutant individuals by genetic marker screening, and finally sequencing and identifying each single cell or mutant individual. Such a strategy is very blind and will undoubtedly consume a lot of time and economic costs. Therefore, in order to overcome the limitations of existing methods, save labor costs, improve the application level of genome editing technology, and study gene function faster and better, it is urgent to develop a molecular tool that can quickly enrich specific editing forms of target genes.

[0005] RNA is a central and universal mediator of genetic information, accurately delivering target DNA sequence information from the nucleus to different cellular compartments with detectable amplified signals. Therefore, we proposed that DNA targets for genome editing might be detected in living cells through their transcribed form, RNA. Recently, ADAR adenosine deaminases have been developed to sense target RNA based on simple Watson-Crick base pairing rules. In this technology, the target RNA information is converted into a downstream signal by translationally reading an in-frame UAG stop codon upstream of a reporter or effector protein, which is edited to UIG and recognized as UGG by the translation machinery in the presence of the target RNA. However, whether this technology can recognize and enrich mutant target RNA transcripts in specific edited forms remains unknown. Summary of the invention

[0006] The present invention provides a method for enriching specific editing forms of target genes based on an RNA sensing system. The method does not require the introduction of any exogenous marker genes into the genome, and can visualize and sort and enrich cells containing specific editing forms in living cells. Moreover, the method can simply and efficiently enrich one or more specific editing forms of target genes at the same time.

[0007] The present invention provides a method for enriching a target gene in a specific editing form based on an RNA sensing system, wherein one or more different RNA sensing systems are introduced into a host for expression, and the basic structure of the RNA sensing system is shown in Formula 1:

[0008] Formula 1 5'XA-(mut-sesRNA)-BY 3'

[0009] Among them, X is the internal reference gene, A is the self-splicing peptide 1, mut-sesRNA is an RNA sequence containing the UAG codon for sensing the presence of trgRNA, and the trgRNA is encoded by the specific editing form of the target gene, B is the self-splicing peptide 2, and Y is the reporter gene;

[0010] Among them, the translation of the internal reference gene is not affected by RNA sensing, and the self-splicing peptide is used to release the internal reference gene and the reporter gene. When the target gene has not undergone gene editing, there is no trgRNA that can match the mut-sesRNA in the host cell, so ADAR cannot be recruited and the reporter gene cannot be translated; when the target gene undergoes a specific form of gene editing, there is trgRNA that can match the mut-sesRNA in the host cell, so ADAR is recruited to change the UAG codon in the mut-sesRNA to the UIG codon, allowing the reporter gene to be translated normally, and then the cells containing the specific editing form of the target gene are enriched through the changes in the expression level of the reporter gene.

[0011] Furthermore, the number of RNA sensing systems is determined according to the number of specific editing forms to be enriched, and the mut-sesRNA sequences, internal reference genes and reporter genes of different RNA sensing systems are different, specifically: the internal reference gene is any fluorescent protein within the detection range of flow cytometry; the self-splicing peptides include T2A, P2A, E2A, and F2A; the reporter gene is any fluorescent protein within the detection range of FACS whose excitation wavelength and emission wavelength are both the same as the internal reference fluorescence without overflow; the mut-sesRNA is a readable nucleic acid sequence that is reverse complementary to the mRNA encoded by the specific editing form of the target gene, and the sequence length is between 3n→3m, n=24, m=116, and sesRNA sequences that are too long or too short will reduce the RNA sensing efficiency.

[0012] Furthermore, one or more plasmid vectors containing the RNA sensing system are introduced into the host cells for expression, and the cells containing the specific edited form of the target gene are enriched by detecting the translation of the reporter gene.

[0013] Furthermore, based on the internal reference fluorescence of the vector, transfection-positive cells are enriched by flow cytometry, and then the cells are sorted according to the fluorescence of the reporter gene. If the edited form of trgRNA can match the mut-sesRNA normally, the reporter gene can be translated normally, which is manifested as an increase in the cell fluorescence intensity. Therefore, cells with fluorescence intensity higher than the control level are cells containing genomic DNA with a mutant sequence in a specific edited form of the target site, and cells with no significant difference from the control level are normal cells or cells containing other edited forms.

[0014] Furthermore, the method is used to enrich specific editing forms of target genes caused by CRISPR / Cas, prime editing and / or base editing.

[0015] Furthermore, the host cells include HEK293T cells, and the target genes include HER2, ActB, TP53, and PCNA.

[0016] Furthermore, the method is for non-disease diagnosis or treatment purposes.

[0017] The present invention also provides the use of any of the aforementioned methods in enriching specific editing forms of target genes.

[0018] Furthermore, the specific editing form is edited by CRISPR / Cas, prime editing, and base editing.

[0019] Furthermore, the application is for non-disease diagnosis or treatment purposes.

[0020] Beneficial effects:

[0021] The method described in the present invention is a non-invasive method that does not require the introduction of any exogenous marker genes into the genome. The transient expression of the reporter gene does not affect the state of the living cells being tested, and visualization and sorting are combined to isolate cells with a specific edited form of the target gene in one step through simple fluorescence microscopy and flow cytometry.

[0022] The method can directly and accurately detect mutations in target DNA in living cells, while previous methods could only provide indirect evidence such as sequencing of neighboring cells, or indicate through transfection selection markers and co-editing marker genes.

[0023] The method can simultaneously enrich one or more specific editing forms of target genes, laying the foundation for high-throughput gene editing experiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0025] Figure 1 It is the enrichment of target site mutation cells in the form of small fragment deletion. Figure A shows the vector structure of the target gene specific editing form enrichment system and the target gene knockout system, as well as a schematic diagram of transfected 293T cells. Figure B shows the working principle of the target gene specific editing form enrichment system. Figures C and D respectively show the fluorescence and fluorescence intensity of 293T cells co-transfected with ses-delete-RNA and sgRNA detected by flow cytometry; Figure E shows the statistics of 4 groups of target sequence mutation forms.

[0026] Figure 2 It is the enrichment of target site mutation cells in the form of small fragment insertion. Figure A shows the vector structure of the target gene specific editing form enrichment system and the target gene lead editing system, as well as the schematic diagram of transfected 293T cells; Figure B shows the working principle of the target gene specific editing form enrichment system; Figures C and D respectively show the fluorescence and fluorescence intensity of 293T cells co-transfected with ses-insert-RNA and pegRNA detected by flow cytometry; Figure E shows the statistics of 4 groups of target sequence mutation forms.

[0027] Figure 3It is the enrichment of target site mutation cells in the form of single base editing. Figure A shows the target gene specific editing form enrichment system and the vector structure of the target gene single base editing system, as well as the schematic diagram of transfected 293T cells; Figure B shows the working principle of the target gene specific editing form enrichment system; Figures C and D respectively show the fluorescence and fluorescence intensity of 293T cells co-transfected with ses-BE-RNA and sgRNA detected by flow cytometry; Figure E shows the statistics of 4 groups of target sequence mutation forms. DETAILED DESCRIPTION

[0028] The following examples are only used to more clearly illustrate the technical scheme of the present invention, and are therefore only used as examples, and cannot limit the scope of protection of the present invention. It should be noted that, unless otherwise stated, the technical terms or scientific terms used in this application should be the usual meanings understood by those skilled in the art to which the present invention belongs. Unless otherwise stated, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art. Unless otherwise stated, the reagents and materials used in the following examples are commercially available.

[0029] Example 1: Enrichment of target site mutation cells with small fragment deletions using a target gene specific editing form enrichment system based on RNA sensing

[0030] This example uses HER2, PCNA, TP53, and ActB genes as examples to verify the effectiveness of the RNA-sensing target gene specific editing form enrichment system in enriching target site mutant cells in the form of small fragment deletions. The working principle is as follows: Figure 1 As shown in Figure B, the mut_mRNA with a 9bp base sequence missing at the target site can normally match the ses_delete sensing RNA to form double-stranded RNA, activate the target gene specific editing form enrichment system to recruit ADAR, and change the stop codon UAG in the sesRNA to the UIG codon, so that the reporter gene (GFP) is translated normally, causing the cell to emit green fluorescence. Other edited forms of mRNA or unedited mRNA cannot match the ses_delete sensing RNA, and thus cannot normally activate the system to recruit ADAR, causing the sesRNA to terminate translation at the stop codon UAG, and GFP cannot be translated, so that the host cell does not show green fluorescence positive.

[0031] The mRNA sequences of target genes HER2, PCNA, TP53, and ActB were downloaded from the NCBI database. The ses_delete sensing RNA was designed using the RADARS GuideDesign Tool (https: / / www.radars.bio / ); the sgRNA was designed using the CCTop-CRISPR / Cas9 target online predictor (https: / / cctop.cos.uni-heidelberg.de:8043). The present invention found in the experimental process that after the editing form enrichment system and the CRISPR / Cas9 system were co-transfected into the cells, there was a certain mutual influence between the two, which in turn affected the editing efficiency of sgRNA and the detection efficiency of sesRNA. Based on this, the present invention optimizes the sequences of sesRNA and sgRNA to avoid the mutual influence between the two systems as much as possible, and effectively improves the detection efficiency while ensuring the editing efficiency. The specific sequences are shown in Table 1.

[0032] Table 1

[0033]

[0034]

[0035] Build Figure 1 The target gene specific editing form enrichment system and target gene knockout system shown in A, where RFP is the internal reference fluorescent gene, GFP is the reporter fluorescent gene, and ses_delete is the sensing RNA that matches the target site deletion of 9bp base sequence. Screen and enrich cells with 9bp base sequence deletion in the genomic target site. The sesRNA consists of a positive control (changing the TAG codon in the sesRNA to TGG), a negative control (changing the TAG codon in the sesRNA to TAA), and ses_delete sensing RNA of four target genes (HER2, PCNA, TP53, ActB); gRNA includes a guide sequence targeting the four target genes (HER2, PCNA, TP53, ActB). The ses-delete-RNA vector and the sgRNA vector were co-transfected into 293T cells, and the fluorescence and intensity of the cells were detected by flow cytometry after 72 hours. As shown Figure 1As shown in C, in the transfected positive cells, only the mut_mRNA with a 9bp base sequence missing at the target site can normally match the ses_delete sensing RNA and complete the translation of the reporter gene (green fluorescent protein), while other edited forms of mRNA cannot be completed. Therefore, in the transfected positive cells, the intensity of green light indicates that the mutant form of the target gene meets the target editing form (9bp missing). If the green light intensity is lower than the negative control level, it indicates that the mutant form of the target gene does not meet the target form.

[0036] Flow cytometry results Figure 1 As shown in D, the cells on the left side of the red dotted line are green fluorescence negative cells, indicating that the enrichment system is not activated, that is, the mutation form of the target site on the genome does not conform to the target form. On the contrary, the cells on the right side of the dotted line are fluorescence positive cells, indicating that the enrichment system is activated, that is, the mutation form of the target site on the genome conforms to the target form (9bp missing). The genomic DNA of the two groups of cells was extracted, and the target sequence was amplified by PCR. The PCR products were analyzed by T cloning and Sanger sequencing. Figure 1 E shows the distribution of mutation forms of the target site sequence. Blue indicates the target mutation form (9bp deletion) and orange indicates other mutation forms of the target site (including WT). P in the horizontal axis indicates positive (positive cells) and N indicates negative (negative cells).

[0037] The results showed that the target gene specific editing form enrichment system had a significant enrichment effect on the target editing form (9bp deletion) mutant sequence, that is, the target gene specific editing form enrichment system can detect and enrich the mutant cells of the CRISPR / cas9-mediated genomic target site specific editing form. Flow cytometry, cell transfection operation is as follows:

[0038] Flow cytometry: The cells in different treatment groups were washed twice with PBS, then 200-500 μL of sterile PBS was used to blow off the cells, and filtered through a 300-mesh cell sieve to separate them into single cell suspensions. The samples in different treatment groups were machine-tested in turn, and the proportion of different fluorescent positive cells in each group was analyzed.

[0039] Transfection of 293T cells: Cells in good condition with a density of 80%-90% were spread on a 12-well cell culture plate with a density of about 70%. The cells in the 12-well plate were cultured overnight until the density reached 80-90%. The plasmid was 1μg and the transfection reagent was 3μL per well during preparation. 200μL DMEM medium (Gibco, New York, USA) was added to a 1.5mL sterile centrifuge tube, and 3μL transfection reagent (Roche's X-treme GENE HP DNA transfection reagent; Roche, Basel, Switzerland) was added, mixed and allowed to stand for 5min. 200μL DMEM medium was added to a 1.5mL sterile centrifuge tube, and 1μg of plasmid was added and mixed. The plasmid mixture was added to the transfection reagent mixture, mixed and allowed to stand for 20min. The entire mixture was added to the culture medium and mixed well. After culturing at 27°C for 6-8h, the culture medium was completely replaced and continued to be cultured. Subsequent tests were performed as needed.

[0040] Example 2: Enrichment of target site mutation cells with small fragment insertions using a target gene specific editing form enrichment system based on RNA sensing

[0041] This example uses HER2, PCNA, TP53, and ActB genes as examples to verify the effectiveness of the RNA-sensing-based target gene specific editing form enrichment system in enriching target site mutant cells in the form of small fragment insertions. The working principle is as follows: Figure 2 As shown in Figure B, similar to Example 1, the mut_mRNA with a 9bp base sequence inserted into the target site can normally match the ses_insert sensing RNA, activating the target gene specific editing form enrichment system so that the cells emit green fluorescence. Other edited forms of mRNA cannot normally activate the system, so that the host cells do not show green fluorescence positive.

[0042] The mRNA sequences of target genes HER2, PCNA, TP53, and ActB were downloaded from the NCBI database. The ses_insert sensing RNA was designed using the RADARS GuideDesign Tool (https: / / www.radars.bio / ); pegRNA was designed using pegFinder: pegRNA designer for Prime Editing (sidichenlab.org), and the sequences are shown in Table 2

[0043] Table 2

[0044]

[0045]

[0046] Build Figure 2 The target gene specific editing form enrichment system and target gene lead editing system shown in A, where RFP is the internal reference fluorescent gene, GFP is the reporter fluorescent gene, and ses_insert is the sensing RNA that matches the target site and inserts a 9bp base sequence. Cells with a 9bp base sequence inserted into the target site of the genome are screened and enriched. The ses-insert-RNA vector and the pegRNA vector are co-transfected into 293T cells, and the fluorescence and intensity of the cells are detected by flow cytometry after 72 hours. Figure 2 As shown in C, in transfected positive cells, only the mut_mRNA with a 9bp base sequence inserted into the target site can normally match the ses_insert sensing RNA and complete the translation of the reporter gene (green fluorescent protein), while other edited forms of mRNA cannot be completed. Therefore, in transfected positive cells, the intensity of green light indicates that the mutant form of the target gene meets the target editing form (insertion of 9bp), and if the green light intensity is lower than the negative control level, it indicates that the mutant form of the target gene does not meet the target form.

[0047] Flow cytometry results Figure 2 As shown in D, the cells on the left side of the red dotted line are green fluorescence negative cells, indicating that the enrichment system is not activated, that is, the mutation form of the target site on the genome does not conform to the target form. On the contrary, the cells on the right side of the dotted line are fluorescence positive cells, indicating that the enrichment system is activated, that is, the mutation form of the target site on the genome conforms to the target form (insertion of 9bp). The genomic DNA of the two groups of cells was extracted, and the target sequence was amplified by PCR. The PCR products were analyzed by T cloning and Sanger sequencing. Figure 2 E shows the distribution of mutation forms of the target site sequence. Blue indicates the target mutation form (9bp insertion), and orange indicates other mutation forms of the target site (including WT). P in the horizontal axis indicates positive (positive cells), and N indicates negative (negative cells).

[0048] The results showed that the target gene specific editing form enrichment system produced a significant enrichment effect on the target editing form (insertion of 9bp) mutant sequence, that is, the target gene specific editing form enrichment system can detect and enrich the mutant cells of the genomic target site specific editing form mediated by prime editing. Flow cytometry and cell transfection operations are the same as in Example 1.

[0049] Example 3: Enrichment of target site mutation cells with single-base editing forms using an RNA-sensing-based target gene specific editing form enrichment system

[0050] This example uses HER2, PCNA, TP53, and ActB genes as examples to verify the effectiveness of the RNA-sensing target gene specific editing form enrichment system in enriching target site mutation cells in the form of single-base editing. The working principle is as follows: Figure 3 As shown in Figure B, similar to Examples 1 and 2, the mut_mRNA of the target site single base editing (CG→TA) sequence can normally match the ses_BE sensing RNA, activating the target gene specific editing form enrichment system so that the cells emit green fluorescence. Other editing forms of mRNA cannot normally activate the system, so that the host cells do not show green fluorescence positive.

[0051] The mRNA sequences of target genes HER2, PCNA, TP53, and ActB were downloaded from the NCBI database. The ses_BE sensing RNA was designed using the RADARS GuideDesign Tool (https: / / www.radars.bio / ); the sgRNA was designed using the CCTop-CRISPR / Cas9target online predictor (https: / / cctop.cos.uni-heidelberg.de:8043), and the sequences are shown in Table 3.

[0052] Table 3

[0053]

[0054]

[0055] Build Figure 3 The target gene specific editing form enrichment system and target gene single base editing system shown in A, where RFP is the internal reference fluorescent gene, GFP is the reporter fluorescent gene, and ses_BE is the sensing RNA that matches the target site single base editing (CG→TA) sequence, to screen and enrich cells with single base editing (CG→TA) at the target genomic site. The ses-BE-RNA vector and sgRNA vector were co-transfected into 293T cells, and the fluorescence and intensity of the cells were detected by flow cytometry after 72 hours. Figure 3 As shown in C, in transfected positive cells, only the mut_mRNA with single-base editing (CG→TA) at the target site can normally match the ses_BE sensing RNA and complete the translation of the reporter gene (green fluorescent protein), while other edited mRNAs cannot be completed. Therefore, in transfected positive cells, the intensity of green light indicates that the mutation form of the target gene meets the target editing form (CG→TA). If the green light intensity is lower than the negative control level, it indicates that the mutation form of the target gene does not meet the target form.

[0056] Flow cytometry results Figure 3 As shown in D, the cells on the left side of the red dotted line are green fluorescence negative cells, indicating that the enrichment system is not activated, that is, the mutation form of the target site on the genome does not conform to the target form. On the contrary, the cells on the right side of the dotted line are fluorescence positive cells, indicating that the enrichment system is activated, that is, the mutation form of the target site on the genome conforms to the target form (CG→TA). The genomic DNA of the two groups of cells was extracted, and the target sequence was amplified by PCR. The PCR products were analyzed by T cloning and Sanger sequencing. Figure 3 E shows the distribution of mutation forms of the target site sequence. Blue represents the target mutation form (CG→TA), and orange represents other mutation forms of the target site (including WT). P in the horizontal axis represents positive (positive cells), and N represents negative (negative cells).

[0057] The results showed that the target gene specific editing form enrichment system produced a significant enrichment effect on the target editing form (CG→TA) mutant sequence, that is, the target gene specific editing form enrichment system can detect and enrich the mutant cells of the genomic target site specific editing form mediated by base editing. Flow cytometry and cell transfection operations were the same as in Example 1.

[0058] The above specific embodiments describe the implementation of the present invention in detail, but the present invention is not limited to the specific details in the above embodiments. Within the scope of the claims and technical concept of the present invention, the technical solution of the present invention can be modified and changed in many simple ways, and these simple modifications all belong to the protection scope of the present invention.

Claims

1. A method for enriching target gene-specific editing forms based on an RNA sensing system, characterized in that: One or more different RNA sensing systems are introduced into the host for expression. The basic structure of the RNA sensing system is shown in Formula 1: Formula 1 5'XA-(mut-sesRNA)-BY 3' Wherein, X is the internal reference gene, A is the self-splicing peptide 1, mut-sesRNA is an RNA sequence containing the UAG codon for sensing the presence of trgRNA, and the trgRNA is encoded by the specific editing form of the target gene, B is the self-splicing peptide 2, and Y is the reporter gene; Among them, the translation of the internal reference gene is not affected by RNA sensing, and the self-splicing peptide is used to release the internal reference gene and the reporter gene. When the target gene has not undergone gene editing, there is no trgRNA that can match the mut-sesRNA in the host cell, so ADAR cannot be recruited and the reporter gene cannot be translated; when the target gene undergoes a specific form of gene editing, there is trgRNA that can match the mut-sesRNA in the host cell, so ADAR is recruited to change the UAG codon in the mut-sesRNA to the UIG codon, allowing the reporter gene to be translated normally, and then the cells containing the specific editing form of the target gene are enriched through the changes in the expression level of the reporter gene.

2. The method according to claim 1, characterized in that The number of RNA sensing systems is determined based on the number of specific editing forms to be enriched, and the mut-sesRNA sequences, internal reference genes, and reporter genes are all different between different RNA sensing systems. Specifically, the internal reference gene is any fluorescent protein within the detection range of flow cytometry; the self-splicing peptides include T2A, P2A, E2A, and F2A; the reporter gene is any fluorescent protein within the detection range of FACS with excitation and emission wavelengths that do not leak with the internal reference fluorescence; the mut-sesRNA is a readable nucleic acid sequence that is reverse complementary to the mRNA encoded by the specific editing form of the target gene, and the sequence length is between 3n→3m, where n=24 and m=116.

3. The method according to any one of claims 1-2, characterized in that One or more plasmid vectors containing RNA sensing systems are introduced into host cells for expression, and cells containing specific edited forms of the target gene are enriched by detecting the translation of the reporter gene.

4. The method according to any one of claim 3, characterized in that: Based on the internal reference fluorescence of the vector, transfection-positive cells are enriched by flow cytometry, and then the cells are sorted according to the fluorescence of the reporter gene. If the edited form of trgRNA can match the mut-sesRNA normally, the reporter gene can be translated normally, which is manifested as an increase in the cell fluorescence intensity. Therefore, cells with fluorescence intensity higher than the control level are cells containing genomic DNA with a mutant sequence in a specific edited form of the target site. Cells with no significant difference from the control level are normal cells or cells containing other edited forms.

5. The method according to any one of claims 1-2, characterized in that: The method is used to enrich for specific editing forms of target genes caused by CRISPR / Cas, prime editing and / or base editing.

6. The method according to claim 3, characterized in that The host cells include HEK293T cells, and the target genes include HER2, ActB, TP53, and PCNA.

7. Use of the method according to any one of claims 1 to 6 for enriching specific editing forms of target genes.

8. The use according to claim 7, characterized in that The specific editing form is edited by CRISPR / Cas, prime editing, and base editing.